Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Affective disorder, Balance disorder, Blood pressure fluctuation, Exercise lack of, Fatigue
Clinical narrative: syncope; Memory concentration problems; blood pressure up and down; muscle weakness; balance problems; slow to walk; unable to work for weeks; fatigue; nerve pain; tremors; unable to exercise; heat intolerance; UTI; mood problems; palpitations; muscle spasms; jaw pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12May2021 as dose 2, single (Lot number: EW0175) at the age of 58 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Past drug history included: Yes, reaction(s): "Allergy", notes: known allergies Yes. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: EW0162, Location of injection: Arm Left), administration date: 16Apr2021, when the patient was 58-year-old, for COVID-19 immunization. The following information was reported: MEMORY IMPAIRMENT (non-serious) with onset 12May2021, outcome "recovered with sequelae", described as "Memory concentration problems"; URINARY TRACT INFECTION (non-serious) with onset 12May2021, outcome "recovered with sequelae", described as "UTI"; BALANCE DISORDER (non-serious) with onset 12May2021, outcome "recovered with sequelae", described as "balance problems"; BLOOD PRESSURE FLUCTUATION (non-serious) with onset 12May2021, outcome "recovered with sequelae", described as "blood pressure up and down"; FATIGUE (non-serious) with onset 12May2021, outcome "recovered with sequelae"; TEMPERATURE INTOLERANCE (non-serious) with onset 12May2021, outcome "recovered with sequelae", described as "heat intolerance"; PAIN IN JAW (non-serious) with onset 12May2021, outcome "recovered with sequelae", described as "jaw pain"; AFFECTIVE DISORDER (non-serious) with onset 12May2021, outcome "recovered with sequelae", described as "mood problems"; MUSCLE SPASMS (non-serious) with onset 12May2021, outcome "recovered with sequelae"; MUSCULAR WEAKNESS (non-serious) with onset 12May2021, outcome "recovered with sequelae", described as "muscle weakness"; NEURALGIA (non-serious) with onset 12May2021, outcome "recovered with sequelae", described as "nerve pain"; PALPITATIONS (non-serious) with onset 12May2021, outcome "recovered with sequelae"; GAIT DISTURBANCE (non-serious) with onset 12May2021, outcome "recovered with sequelae", described as "slow to walk"; SYNCOPE (medically significant) with onset 12May2021, outcome "recovered with sequelae"; TREMOR (non-serious) with onset 12May2021, outcome "recovered with sequelae", described as "tremors"; EXERCISE LACK OF (non-serious) with onset 12May2021, outcome "recovered with sequelae", described as "unable to exercise"; LOSS OF EMPLOYMENT (non-serious) with onset 12May2021, outcome "recovered with sequelae", described as "unable to work for weeks". The events "syncope", "memory concentration problems", "blood pressure up and down", "muscle weakness", "balance problems", "slow to walk", "unable to work for weeks", "fatigue", "nerve pain", "tremors", "unable to exercise", "heat intolerance", "uti", "mood problems", "palpitations", "muscle spasms" and "jaw pain" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (11Mar2022) Negative, notes: Nasal Swab. Therapeutic measures were taken as a result of syncope, memory impairment, blood pressure fluctuation, muscular weakness, balance disorder, gait disturbance, loss of employment, fatigue, neuralgia, tremor, exercise lack of, temperature intolerance, urinary tract infection, affective disorder, palpitations, muscle spasms, pain in jaw.  Clinical course:ae treatment: Antibiotics referrals to specialists meds. Patient did not have Covid prior vaccination. Patient did not received other vaccine in 4 weeks. Patient did not received other medications in 2 weeks. Patient had known allergies.  Follow-up attempts are completed. No further information is expected.